As Nigeria’s Senate prepares for its third debate on the National Bill for Sickle Cell Disease (SCD), a new study underscores the need for a cohesive national legal framework. Released by Nguvu Change Leader Onor-obassi Tawo and the Nigerian Nguvu Collective during Sickle Cell Awareness Month, the study—”A Comparative Study of Existing Sickle Cell Laws in Four Nigerian States”—examines the laws in Anambra, Kano, Kaduna, and Abia, highlighting crucial inconsistencies and gaps.
The study points out significant disparities in public awareness, law enforcement, and access to genotype screening services across these states. While Anambra shows progress in advocacy, states like Kano, Kaduna, and Abia lag behind in public awareness. “This report emphasizes the urgent need to address these discrepancies to improve outcomes for SCD patients nationwide,” said Obassi-Tawo.
Despite commendable federal initiatives such as newborn screening and sickle cell centers, the study reveals that substantial investment and coordinated efforts are essential to tackle the burden of SCD effectively. With 4-6 million Nigerians carrying the sickle cell trait, the proposed national Act could standardize state practices and improve public health outcomes while respecting individual rights.
Key findings from the study include:
– Awareness Discrepancies: There is a marked variation in awareness of sickle cell laws, with Kaduna showing low awareness about premarital screening laws compared to Anambra, where advocacy efforts have been more effective.
– Inconsistent Implementation: States vary in their enforcement and interpretation of sickle cell laws, leading to uneven implementation and gaps in enforcement.
– Access and Affordability Issues: Many rural areas face challenges in accessing and affording genotype screening, exacerbated by insufficient resources in Primary Health Care centers.
– Cultural and Religious Barriers: Socio-cultural and religious factors often impede genotype screening and contribute to stigma against individuals with SCD, affecting public health initiatives.
The study, using in-depth interviews, social media monitoring, and comparative legal analysis, provides actionable recommendations:
1. Increase Public Awareness: Develop clear and accessible messaging to enhance understanding of genotype screening and SCD.
2. Engage Cultural and Religious Leaders: Use their influence to spread information and support public health initiatives in underserved areas.
3. Improve Healthcare Access: Ensure universal healthcare that makes treatment and services affordable for SCD patients.
4. Establish Ethical Guidelines: Protect individuals’ rights by enforcing confidentiality and preventing discrimination during screenings.
These recommendations aim to guide policymakers in crafting a comprehensive national framework to better manage and reduce the impact of SCD in Nigeria.
